Management of Therapeutic Failure due to Clinical Resistance to Botulinum Neurotoxin Type A in Chronic Pediatric Patients: Evidence of Response Recovery After Switching to IncobotulinumtoxinA

Toxicon 2026

View at publisher

Authors: Mirley Echevarría Ulloa, Andreea Mihaela Dumitrescu Florescu, Paz Martín Maroto, María Olga Arroyo Riaño

DOI: 10.1016/j.toxicon.2025.108735

Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments Cardiovascular Syncope and Autonomic Disorders